1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
3.2. DEVELOPMENT OF BIOCHIPS
3.3. MARKET DEFINITION
3.4. KEY DRIVERS
3.4.1. RISING INCIDENCES OF CHRONIC DISEASES
3.4.2. GROWING INTEREST IN PERSONALIZED MEDICINES
3.4.3. APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
3.4.4. RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
3.5. KEY RESTRAINTS
3.5.1. HIGH INSTRUMENTATION COST
3.5.2. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
3.5.3. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
3.5.4. COMPLEXITY OF BIOLOGICAL SYSTEMS
3.5.5. LACK OF COMMON REGULATORY STANDARDS

4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOCHIPS
4.2. KEY INVESTMENT INSIGHTS
4.3. PORTER’S FIVE FORCE ANALYSIS
4.3.1. BUYER POWER
4.3.2. SUPPLIER POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.6.1. RESEARCH & DEVELOPMENT
4.6.2. RAW MATERIALS
4.6.3. MANUFACTURING
4.6.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
4.6.5. END-USER
4.7. KEY BUYING CRITERIA
4.7.1. COST
4.7.2. APPLICATIONS
4.7.3. PRODUCT TYPE
4.8. REGULATORY FRAMEWORK

5. MARKET BY TYPE
5.1. DNA CHIPS
5.1.1. AGRICULTURAL BIOTECHNOLOGY
5.1.2. CANCER DIAGNOSIS & TREATMENT
5.1.3. DRUG DISCOVERY
5.1.4. GENE EXPRESSION
5.1.5. GENOMICS
5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
5.1.7. OTHER DNA CHIPS
5.2. LAB ON A CHIP
5.2.1. CLINICAL DIAGNOSTICS
5.2.2. DRUG DISCOVERY
5.2.3. GENOMICS
5.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
5.2.5. PROTEOMICS
5.2.6. OTHER LAB ON A CHIP
5.3. PROTEIN CHIPS
5.3.1. DIAGNOSTICS
5.3.2. DRUG DISCOVERY
5.3.3. EXPRESSION PROFILING
5.3.4. HIGH THROUGHPUT SCREENING
5.3.5. PROTEOMICS
5.3.6. OTHER PROTEIN CHIPS
5.4. OTHER TYPES
5.4.1. CELL ARRAYS
5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS
6.1. GLASS
6.2. POLYMERS
6.3. SILICON
6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USER
7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.2. HOSPITALS AND DIAGNOSTICS CENTERS
7.3. ACADEMIC AND RESEARCH INSTITUTES

8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES
8.1.2. CANADA

9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES INC
9.2. AGILENT TECHNOLOGIES INC
9.3. BIOCHAIN INSTITUTE INC
9.4. BIOMÉRIEUX SA
9.5. BIO-RAD LABORATORIES INC
9.6. CEPHEID
9.7. CYBRDI INC
9.8. F HOFFMANN-LA ROCHE LTD
9.9. FLUIDIGM CORPORATION
9.10. GE HEALTHCARE
9.11. ILLUMINA INC
9.12. MERCK KGAA
9.13. PERKINELMER INC
9.14. RANDOX LABORATORIES LTD
9.15. THERMO FISHER SCIENTIFIC INC